Search Results - "Üstün, C."

Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival by Lunde, L E, Dasaraju, S, Cao, Q, Cohn, C S, Reding, M, Bejanyan, N, Trottier, B, Rogosheske, J, Brunstein, C, Warlick, E, Young, J A H, Weisdorf, D J, Ustun, C

“…Although hemorrhagic cystitis (HC) is a common complication of allogeneic hematopoietic cell transplantation (alloHCT), its risk factors and effects on…”
Get full text

To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century by Ustun, C, Lazarus, H M, Weisdorf, D

“…AML treatment presents significant challenges in the elderly, who more often have poor risk cytogenetic and molecular markers, comorbidities and compromised…”
Get full text

Locking plate fixation versus antegrade intramedullary nailing for the treatment of extra-articular distal femoral fractures by Ocalan, E., Ustun, C.C., Aktuglu, K.

“…•What makes our study valuable is the comparison of the functional results. The AIN group had a significantly higher Lysholm Functional Knee Score.•Anterior…”
Get full text

Process of allogeneic hematopoietic cell transplantation decision making for older adults by Randall, J, Keven, K, Atli, T, Ustun, C

“…Allogeneic hematopoietic cell transplantation (alloHCT) may be the only curative option for some older adults with hematologic malignancies, and its associated…”
Get full text

Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis by Ustun, C, Giannotti, F, Zhang, M-J, Wang, H-L, Brunstein, C, Labopin, M, Rocha, V, de Lima, M, Baron, F, Sandmaier, B M, Eapen, M, Gluckman, E, Nagler, A, Weisdorf, D J, Ruggeri, A

“…Allogeneic hematopoietic cell transplantation (HCT) from siblings or unrelated donors (URD) during complete remission (CR) may improve leukemia-free survival…”
Get full text

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal by Valent, P., Sotlar, K., Sperr, W.R., Escribano, L., Yavuz, S., Reiter, A., George, T.I., Kluin-Nelemans, H.C., Hermine, O., Butterfield, J.H., Hägglund, H., Ustun, C., Hornick, J.L., Triggiani, M., Radia, D., Akin, C., Hartmann, K., Gotlib, J., Schwartz, L.B., Verstovsek, S., Orfao, A., Metcalfe, D.D., Arock, M., Horny, H.-P.

“…Mast cell leukemia (MCL), the leukemic manifestation of systemic mastocytosis (SM), is characterized by leukemic expansion of immature mast cells (MCs) in the…”
Get full text

Fusariosis manifesting as targetoid purpuric cutaneous lesions in immunocompromised patients by Erdemoglu, Y., Aydingoz, I.E., Ustun, C., Uzay, A., Besli, Y., Ozturk Durmaz, E., Demirkesen, C., Sahin, S.

Get full text

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice by Ustun, Celalettin, Arock, Michel, Kluin-Nelemans, Hanneke C, Reiter, Andreas, Sperr, Wolfgang R, George, Tracy, Horny, Hans-Peter, Hartmann, Karin, Sotlar, Karl, Damaj, Gandhi, Hermine, Olivier, Verstovsek, Srdan, Metcalfe, Dean D, Gotlib, Jason, Akin, Cem, Valent, Peter

“…Systemic mastocytosis is a heterogeneous disease characterized by the accumulation of neoplastic mast cells in the bone marrow and other organ organs/tissues…”
Get full text

Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation by Bejanyan, N, Oran, B, Shanley, R, Warlick, E, Ustun, C, Vercellotti, G, Verneris, M, Wagner, J E, Weisdorf, D, Brunstein, C

“…AML relapse remains the leading cause of transplant failure among Allo-SCT recipients. A single institution study was conducted on 348 patients with AML who…”
Get full text

MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes by Pourhassan, H, DeFor, T, Trottier, B, Dolan, M, Brunstein, C, Bejanyan, N, Ustun, C, Warlick, E D

“…Myelodysplastic syndrome (MDS) is a heterogeneous group of hematological malignancies with considerably variable prognoses and curable only with hematopoietic…”
Get full text

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study by Maziarz, R T, Brazauskas, R, Chen, M, McLeod, A A, Martino, R, Wingard, J R, Aljurf, M, Battiwalla, M, Dvorak, C C, Geroge, B, Guinan, E C, Hale, G A, Lazarus, H M, Lee, J-W, Liesveld, J L, Ramanathan, M, Reddy, V, Savani, B N, Smith, F O, Strasfeld, L, Taplitz, R A, Ustun, C, Boeckh, M J, Gea-Banacloche, J, Lindemans, C A, Auletta, J J, Riches, M L

“…Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic cell transplantation (HSCT). However, little is known…”
Get full text

Comparison of the efficacy of medium chain triglycerides with long chain triglycerides in total parenteral nutrition in patients with hematologic malignancies undergoing peripheral blood stem cell transplantation by DEMIRER, S., AYDINTU Ǧ, S., ÜSTÜN, C., TÜRKMEN, E., TÜZÜN, A., ŞIMSEK, Ş., BASARAN, Ö., ÇELEBI, H., DEMIRER, T.

“…Background and aims: The purpose of this randomized study was to compare the efficacy of medium chain triglycerides (MCT) plus long chain triglycerides (LCT)…”
Get full text

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML by Ustun, C, Wiseman, A C, DeFor, T E, Yohe, S, Linden, M A, Oran, B, Burke, M, Warlick, E, Miller, J S, Weisdorf, D

“…Reduced-intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (allo-HCT) can cure patients with AML in CR. However, relapse after RIC…”
Get full text

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation by Ustun, C, Brunstein, C, DeFor, T, Rashidi, A, Yohe, S, Bejanyan, N, Cooley, S, Warlick, E, Miller, J, Linden, M A, Weisdorf, D

Get full text

Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome by Trottier, B J, Sachs, Z, DeFor, T E, Shune, L, Dolan, M, Weisdorf, D J, Ustun, C, Warlick, E D

“…Among patients with myelodysplastic syndrome (MDS) undergoing hematopoietic cell transplantation (HCT), the impact of residual pretransplant cytogenetically…”
Get full text

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies by Gürman, G., Arat, M., Ilhan, O., Konuk, N., Beksaç, M., Çelebi, H., Özcan, M., Arslan, Ö., Üstün, C., Akan, H., Uysal, A., Koç, H.

“…The effect of allogeneic hematopoietic cell transplantation (alloHCT) on hematologic malignancies is based on the graft-versus-malignancy effect. Obtaining…”
Get full text

P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS by DeAngelo, D. J., Pullarkat, V., Piris‐Villaespesa, M., George, T. I., Patel, J. L., Ustun, C., Bose, P., Heaney, M. L., Pilla, A., Massaro, M., Exter, B., Jolin, H. A., Mikhak, Z., Tashi, T.

Get full text

Nasal GVHD by Randall, N, Boyer, H, Martin, P J, Weisdorf, D, Burns, L J, Ustun, C

Get full text

β-Thalassemia: early antenatal diagnosis by KOCAK, I, ÜSTÜN, C, TEKSEN, F

Get full text

Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT by Bachanova, V, Cao, Q, Ustun, C, Kendi, A T K, Froelich, J, Lazaryan, A, Burns, L J

Get full text